Biomarqueurs cardiaques

Jeudi 14 Janvier 2016   16:00-17:30   Salle 343
Communications libres
16:00 • Corentin Curinier
SST2 provides significantly additional prognostic information when compared to NT-proBNP in ambulatory patient with heart failure
16:15 • Amira Zaroui
Detection of myocardial fibrosis in patients with hypertrophic cardiomyopathy evaluated by biological markers
16:30 • Céline Bégué
Mid-regional pro-atrial natriuretic peptide for predicting mortality and morbidity in hypertrophic cardiomyopathy: a comparison with N-terminal pro-brain natriuretic peptide
16:45 • François Roubille
Galectin 3 for risk stratification in ambulatory heart failure patients
17:00 • Salma Charfeddine
The role of brain natriuretic peptide and cystatin C in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes after myocardial infarction in patients without heart failure symptoms
Utility of research of the QT/QT-c intervals dispersion and cardiac biomarkers for early diagnosis of anthracycline induced cardiotoxicity in children